Circassia Pharmaceuticals (CIRL)

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 0.000p
  • 52 Week Low: 0.000p
  • Currency: UK Pounds
  • Shares Issued: 284.89m
  • Volume: 0

CIRL Overview

Niox Group is a specialty biopharmaceutical company focused on the development and commercialisation of a range of immunotherapy product candidates for the treatment of allergy.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0%
Div Cover n/a
Op Mrgn 18.4%
ROCE 21.4%
Latest F'cast
P/E n/a
PEG n/a
Pr/Revenue n/a
Pr/Book n/a
Latest F'cast
Revenue 13.6%
PBT 90.2%
EPS -41.3%
DPS n/a

CIRL Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 23.90 (18.40) (7.00)p n/a n/a n/a n/a 0.0%
31-Dec-21 27.90 (2.10) 0.55p 71.1 n/a n/a n/a 0.0%
31-Dec-22 31.30 10.50 2.73p n/a n/a +396% n/a 0.0%
31-Dec-23 36.80 4.10 3.87p n/a n/a +42% n/a 0.0%
31-Dec-24 41.80 7.80 2.27p n/a n/a -41% n/a 0.0%

CIRL Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 46.86 10.43 3.48p n/a n/a +54% 1.17p 0.0%
31-Dec-26 52.37 12.63 3.98p n/a n/a +14% 1.28p 0.0%
31-Dec-27 57.79 15.66 4.92p n/a n/a +24% 1.50p 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

CIRL ShareCast News

No recent information was found.

Latest CIRL Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 5 minutes.

Note 2: Forecast figures based on normalised accounts.

 

CIRL Market Data

Currency UK Pounds
Share Price 0.000p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 0.000p
52 Week Low 0.000p
Volume 0
Shares Issued 284.89m

What The Brokers Say

Strong Buy 3
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 4
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

CIRL Key Personnel

CEO Jonathan Emms

Top of Page